Roivant Sciences Ltd (ROIV) Price Prediction & ForecastROIVRoivant Sciences Ltd

Alphio's ROIV stock price prediction model matches the current Roivant Sciences Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $33.34 (-0.57%). The 1-week path is $34.01 (+1.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Roivant Sciences Ltd (ROIV) is a good buy right now due to its current price of $33.53, which is significantly below the average analyst price target of $46. Additionally, the stock has shown strong momentum with a year-to-date change of +52.90% and a one-year change of +89.01%. The recent positive Phase 2 trial results for its treatment mosliciguat have prompted analysts to raise their price targets, indicating strong growth potential. However, the stock has a relatively low RSI of 33.124, suggesting it may be oversold, which could present a buying opportunity. The main risk is the negative net income reported in Q3 2026 of -265.89 million USD, which reflects ongoing financial challenges that investors should consider.

Roivant Sciences Ltd (ROIV) last closed at $33.53, losing -1.50%. These facts feed the 1-day and 1-week ROIV price prediction above.